Sequana Medical NV (SEQUA) NPV

Sell:€2.14Buy:€2.15€0.06 (2.73%)

Prices delayed by at least 15 minutes
Sell:€2.14
Buy:€2.15
Change:€0.06 (2.73%)
Prices delayed by at least 15 minutes
Sell:€2.14
Buy:€2.15
Change:€0.06 (2.73%)
Prices delayed by at least 15 minutes

Company Information

About this company

Sequana Medical NV is a Belgium-based company, which manufactures medical devices. The Company focuses mainly on the development of treatment solutions for the management of liver disease, heart failure, malignant ascites and other fluid imbalance disorders. Sequana Medical NV provides alfapump, which is an implantable, programmable, wireless-charged and battery-powered system that is CE-marking for the management of refractory ascites due to liver cirrhosis and malignant ascites. Over 650 alfapump systems have been implanted. Apart from the Alfapump, the Company also aims to develop a direct sodium removal (DSR) therapy, which is a propriety approach to the treatment of volume overload in heart failure.

Key people

Ian Crosbie
Chief Executive Officer, Executive Director
Kirsten Van Bockstaele
Chief Financial Officer
Dirk Fengels
Global Vice President Engineering and Manufacturing
Timur Resch
Global Vice President Quality Management and Regulatory Affairs
Martijn Blom
Chief Commercial Officer
Gijs Klarenbeek
Chief Medical Officer
Pierre Hubert Andre Chauvineau
Non-Executive Independent Chairman of the Board
Rudy Dekeyser
Non-Executive Director
Alexandra Clyde
Non-Executive Independent Director
Jackie Fielding
Non-Executive Independent Director
Douglas W. Kohrs
Non-Executive Independent Director
Click to see more

Key facts

  • EPIC
    -
  • Location
    Belgium
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    BE0974340722
  • Market cap
    €115.32m
  • Employees
    62
  • Shares in issue
    52.42m
  • Exchange
    Euronext Brussels
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.